Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+55.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+55.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.48M | +31.9% |
| 2024 | $10.98M | +32.4% |
| 2023 | $8.30M | +113.7% |
| 2022 | $3.88M | +460.9% |
| 2021 | $-1.08M | +86.3% |
| 2020 | $-7.87M | -3198.0% |
| 2019 | $254000.00 | - |